Trial Profile
Remission Induction of Very Early Rheumatoid Arthritis with Methotrexate and Etanercept
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Etanercept (Primary) ; Methotrexate (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 05 Sep 2009 New trial record.